Advisornet Financial’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.03K | Buy |
1,762
+1,633
| +1,266% | +$2.81K | ﹤0.01% | 1743 |
|
|
2025
Q1 | $430 | Buy |
+129
| New | +$430 | ﹤0.01% | 1965 |
|
|
2022
Q3 | – | Sell |
-2,283
| Closed | -$25K | – | 1924 |
|
|
2022
Q2 | $25K | Hold |
2,283
| – | – | ﹤0.01% | 1049 |
|
|
2022
Q1 | $38K | Sell |
2,283
-488
| -18% | -$8.12K | ﹤0.01% | 1040 |
|
|
2021
Q4 | $53K | Sell |
2,771
-212
| -7% | -$4.06K | ﹤0.01% | 986 |
|
|
2021
Q3 | $74K | Sell |
2,983
-63
| -2% | -$1.56K | 0.01% | 883 |
|
|
2021
Q2 | $79K | Sell |
3,046
-3,039
| -50% | -$78.8K | 0.01% | 841 |
|
|
2021
Q1 | $193K | Sell |
6,085
-5,695
| -48% | -$181K | 0.01% | 566 |
|
|
2020
Q4 | $547K | Buy |
11,780
+440
| +4% | +$20.4K | 0.04% | 322 |
|
|
2020
Q3 | $373K | Buy |
11,340
+450
| +4% | +$14.8K | 0.03% | 379 |
|
|
2020
Q2 | $299K | Buy |
10,890
+7,010
| +181% | +$192K | 0.02% | 429 |
|
|
2020
Q1 | $116K | Buy |
+3,880
| New | +$116K | 0.01% | 575 |
|
|
2019
Q2 | – | Sell |
-800
| Closed | -$8K | – | 1737 |
|
|
2019
Q1 | $8K | Buy |
+800
| New | +$8K | ﹤0.01% | 1233 |
|